Concourse Financial Group Securities’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Concourse Financial Group Securities’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-275	Closed	-$9.72K	–	2293
2021 Q4	$12K	Hold	275	–	–	﹤0.01%	1807
2021 Q3	$14K	Hold	275	–	–	﹤0.01%	1770
2021 Q2	$14K	Hold	275	–	–	﹤0.01%	1757
2021 Q1	$13K	Hold	275	–	–	﹤0.01%	1691
2020 Q4	$13K	Hold	275	–	–	﹤0.01%	1603
2020 Q3	$11K	Buy	+275	New	+$10.6K	﹤0.01%	1542

Other funds holding IDNA

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Concourse Financial Group Securities's IDNA Position: Q1 2022 in Review

Concourse Financial Group Securities sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q1 2022, closing a stake of 275 shares — an estimated $9.72K sold.

Concourse Financial Group Securities first reported a position in IDNA in Q3 2020 and held it in 6 quarters. The position peaked at $14K in Q3 2021. 86 funds tracked by Wall St. Rank hold IDNA as of Q1 2022.

Concourse Financial Group Securities reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q1 2022 after selling out during the quarter.
Concourse Financial Group Securities sold 275 iShares Genomics Immunology and Healthcare ETF shares in Q1 2022, an estimated $9.72K.
Concourse Financial Group Securities first reported a position in iShares Genomics Immunology and Healthcare ETF in Q3 2020 and held it in 6 quarters.
Concourse Financial Group Securities's iShares Genomics Immunology and Healthcare ETF position peaked at $14K in Q3 2021.
86 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2022.

Based on Concourse Financial Group Securities's 13F filing for Q1 2022, filed 9 May 2022.